| TEMPLATE ID | Nuclear medicine oncological therapy |
|---|---|
| Concept | Nuclear medicine oncological therapy |
| Description | Not Specified |
| Purpose | Not Specified |
| References | |
| Authors | date: 2019-12-03; email: rehberg.alina@mh-hannover.de; organisation: Medizinische Hochschule Hannover; name: Alina Rehberg |
| Other Details Language | date: 2019-12-03; email: rehberg.alina@mh-hannover.de; organisation: Medizinische Hochschule Hannover; name: Alina Rehberg |
| Other Details (Language Independent) |
|
| Language used | en |
| Citeable Identifier | 1246.169.3400 |
| Root archetype id | openEHR-EHR-COMPOSITION.report.v1 |
| Nuclear medicine oncological therapy | Nuclear medicine oncological therapy: Document to communicate information to others, commonly in response to a request from another party. |
| Other Context | |
| Report ID | Report ID: Identification information about the report. |
| Status | Status: The status of the entire report. Note: This is not the status of any of the report components.
|
| Case identification | Case identification: To record case identification details for public health purposes. |
| Case identifier | Case identifier: The identifier of this case. |
| Nuclear medicine therapy | Nuclear medicine therapy: A clinical activity carried out for screening, investigative, diagnostic, curative, therapeutic, evaluative or palliative purposes. |
| Description | |
| Procedure name | Procedure name: Identification of the procedure by name. Coding of the specific procedure with a terminology is preferred, where possible. Value set: terminology://fhir.hl7.org//ValueSet/$expand?url=http://highmed.org/fhir/ValueSet/onko/therapiemethode |
| Description | Description: Narrative description about the procedure, as appropriate for the pathway step. For example: description about the performance and findings from the the procedure, the aborted attempt or the cancellation of the procedure. |
| Relation to the operation | Relation to the operation: To illustrate the relationship between radiation therapy, systemic therapy and/or other therapy and surgical therapy (OP). |
| Position on surgery | Position on surgery: The relationship between radiation therapy, systemic therapy or other therapy to surgical therapy (OP).
|
| Therapy response | Therapy response: Evaluation of the response of a disease to therapy. This helps to assess the success of treatment, e.g. radiation or chemotherapy for a tumor. |
| Overall response | Overall response: Term that describes the response to treatment of a disease. This is an already coded terminology of response to, for example, oncological therapy. Symptoms can be, for example, CR (complete remission of the disease), PR (partial remission), SD (stable disease) or PD (progression of the disease). Value set: terminology://fhir.hl7.org//ValueSet/$expand?url=http://highmed.org/fhir/ValueSet/onko/therapieansprechen |
| Comment | Comment: Comment field on treatment response. |
| Irradiation | Irradiation: Detailed information about the irradiation in radiotherapy. |
| Anatomical location | Anatomical location: A physical site on or within the human body. |
| Body site name | Body site name: Identification of a single physical site either on, or within, the human body. This data element is the only mandated data point in this archetype and should be used as the primary data point to record an anatomical location with a commonly used name. It is strongly recommended that 'Body site name' be recorded as specifically as is anatomically possible. For example: record 'upper eyelid' rather than recording 'eyelid' with 'upper' as a qualifier; 'fifth rib' rather than 'rib' with a numeric qualifier. Use the other data elements for laterality, aspect, region and anatomical line to provide more detail. This data element should be coded with a terminology capable of triggering decision support, where possible - an appropriate termset for use here could comprise individual concepts or a list of precoordinated terms. Free text should be used only if there is no appropriate terminology available. If body site name is already identified in the parent archetype, then this data element may be redundant. Alternatively, a use case has been identified where the value may be duplicated into this element to support semantic querying using this archetype, rather than the data element within the parent. Terminology: Target area
|
| Specific body site/target volume | Specific body site/target volume: Additional detail using a specific region or a point on, or within, the identified body site. Use to increase precision of identification of the body site, if required. For example, the upper right quadrant or McBurney's point on the abdominal wall or interphalangeal joint of the great toe. If the 'Body site name' data element uses pre-coordinated terms that include the specific site, then this data element is redundant.
|
| Start | Start: The date, on which the radiotherapy of the target region was started. |
| End | End: The date, on which the radiotherapy of the target region was ended. |
| Treatment method | Treatment method: Description of the technical procedure. Depending on how the radiation penetrates the body, different methods of irradiation are distinguished.
|
| Application type | Application type: Irradiation technique, as a further classification of the treatment method. The techniques of irradiation are diverse. If possible, encoding with a terminology is preferred. Value set: terminology://fhir.hl7.org//ValueSet/$expand?url=http://highmed.org/fhir/ValueSet/onko/applikationsart-nuklearmedizinische-therapie |
| Single dose | Single dose: The single dose used to irradiated the target region. The dose refers to the prescribed isodose (equal energy or ion dose on a line or area). |
| Dose (ED) | Dose (ED): The value of the single dose. Example: When specifying radiation dose 3.0 Gy, the value is '3.0'. 0..999.999 |
| Unit (ED) | Unit (ED): The unit in which the single dose was specified. The individual dose in radiation therapy is usually recorded in grays (Gy) and less frequently in gigabequerels (GBq). For a radiation dose of '3.0 Gy', the unit for the dose is 'Gy'. For a radiation dose of '2.6 GBq', the unit for the dose is 'GBq'.
|
| Total dose | Total dose: The total dose used to irradiate the
target region. The total dose is composed of several individual doses (fractions). For example: 30.0 Gy can be administered in 10 fractions of 3.0 Gy each. |
| Dose (SD) | Dose (SD): The value of the total dose. Example: When indicating radiation dose of 30.0 Gy, the value is '30.0'. 0..999.999 |
| Unit (SD) | Unit (SD): The unit in which the total dose was
specified. The individual dose in radiation therapy is usually recorded in grays (Gy) and less frequently in gigabequerels (GBq). For a radiation dose of '30.0 Gy', the unit for the dose is 'Gy'. For a radiation dose of '26.0 GBq', the unit for the dose is 'GBq'.
|
| Side effects | Side effects: Reported observation of a physical or mental disturbance in an individual. |
| Symptom/Sign name | Symptom/Sign name: The name of the reported symptom or sign. Symptom name should be coded with a terminology, where possible. |
| Nil significant | Nil significant: The identified symptom or sign was reported as not being present to any significant degree. Record as True if the subject of care has reported the symptom as not significant. For example: if the individual has never experienced the symptom it is appropriate to record 'nil significant'; or if the individual commonly experiences the symptom, in some circumstances it may be considered appropriate to record 'nil significant' if the individual has experienced no deviation from their 'normal' baseline. |
| Outcome | Outcome: Outcome of procedure performed. Coding with a terminology is preferred, where possible. Value set: terminology://fhir.hl7.org//ValueSet/$expand?url=http://highmed.org/fhir/ValueSet/onko/therapieende-grund |
| Reason | Reason: Reason that the activity or care pathway step for the identified procedure was carried out. For example: the reason for the cancellation or suspension of the procedure. Value set: terminology://fhir.hl7.org//ValueSet/$expand?url=http://highmed.org/fhir/ValueSet/onko/intention-der-therapie |
| Comment | Comment: Additional narrative about the activity or care pathway step not captured in other fields. |
| Protocol | |
| Nuklearmedizische Therapie ID | Nuklearmedizische Therapie ID: The local ID assigned to the order by the healthcare provider or organisation requesting the service. This is equivalent to Placer Order Number in HL7 v2 specifications.
|
| Tumordiagnosis_section | Tumordiagnosis_section: Framework for consistent modelling of content within a template for a Problem list. Intended to be used within the COMPOSITION.problem_list. |
| Tumor diagnosis | Tumor diagnosis: Details about a single identified health condition, injury, disability or any other issue which impacts on the physical, mental and/or social well-being of an individual. Clear delineation between the scope of a problem versus a diagnosis is not easy to achieve in practice. For the purposes of clinical documentation with this archetype, problem and diagnosis are regarded as a continuum, with increasing levels of detail and supportive evidence usually providing weight towards the label of 'diagnosis'. |
| Data | |
| Diagnosis Name (ICD-10) | Diagnosis Name (ICD-10): Identification of the problem or diagnosis, by name. Coding of the name of the problem or diagnosis with a terminology is preferred, where possible. |
| Variant | Variant: Specific variant or subtype of the Diagnosis, if relevant. For example: 'acute motor axonal neuropathy' as a variant of Guillain-Barre Syndrome. Coding of the name of the variant with a terminology is preferred, where possible. |
| Clinical description | Clinical description: Narrative description about the problem or diagnosis. Use to provide background and context, including evolution, episodes or exacerbations, progress and any other relevant details, about the problem or diagnosis. |
| Date/time of onset | Date/time of onset: Estimated or actual date/time that signs or symptoms of the problem/diagnosis were first observed. Data captured/imported as "Age at onset" should be converted to a date using the subject's date of birth. |
| Protocol | |
| Tumor ID | Tumor ID: To display the ID of the tumor. |
| Tumor ID | Tumor ID: The ID/identifier of the tumor. |